Kuhn, A. J., Outlaw, V. K., Marcink, T. C., Yu, Z., Mears, M. C., Cajimat, M. N., Kreitler, D. F., Cleven, P. R., Mook, J. C., Bente, D. A., Porotto, M., Gellman, S. H., & Moscona, A. (2025). Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development. Journal of Virology. https://doi.org/10.1128/jvi.02159-24

Bradford Bertumen, J., Benist, S., South, E., Ivy Oyegun, E., Smith-Jeffcoat, S. E., Grijalva, C. G., Zhu, Y., Scott, T. A., Schmitz, J., Chu, H. Y., Weil, A. A., Englund, J. A., MacMillan, M. P., Stockwell, M., McLaren, S. H., Sano, E., Vargas, C., Talbot, K., & Kirking, H. L. (2025). P-2071. 2023-2024 COVID-19 Vaccine Uptake, Knowledge, and Attitudes among Individuals enrolled in a Household Transmission Study, Tennessee, New York, and Washington, January-April 2024. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.2227

Mougari, S., Favède, V., Predella, C., Reynard, O., Durand, S., Mazelier, M., Pizzioli, E., Decimo, D., Bovier, F. T., Lapsley, L. M., Castagna, C., Lieberman, N. A. P., Noel, G., Mathieu, C., Malissen, B., Briese, T., Greninger, A. L., Alabi, C. A., Dorrello, N. V., … Horvat, B. (2025). Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity. Communications Biology, 8(1). https://doi.org/10.1038/s42003-025-07491-4

Hong, S. J., Resnick, S. J., Iketani, S., Cha, J. W., Albert, B. A., Fazekas, C. T., Chang, C.-W., Liu, H., Dagan, S., Abagyan, M. R., Fajtová, P., Culbertson, B., Brace, B., Reddem, E. R., Forouhar, F., Glickman, J. F., Balkovec, J. M., Stockwell, B. R., Shapiro, L., … Chavez, A. (2025). A multiplex method for rapidly identifying viral protease inhibitors. Molecular Systems Biology, 21(2), 158–172. https://doi.org/10.1038/s44320-024-00082-1

Liu, H., Zask, A., Forouhar, F., Iketani, S., Williams, A., Vaz, D. R., Habashi, D., Choi, K., Resnick, S. J., Hong, S. J., Lovett, D. H., Bai, T., Chavez, A., Ho, D. D., & Stockwell, B. R. (2025). Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nature Communications, 16(1). https://doi.org/10.1038/s41467-024-55421-5

Janes, H., Fisher, L. H., Kee, J. J., Parameswaran, L., Goepfert, P. A., Falsey, A. R., Ludwig, J., Magaret, C. A., Gilbert, P. B., Kublin, J. G., Rouphael, N., Sobieszczyk, M. E., El Sahly, H. M., Baden, L. R., Grinsztejn, B., Walsh, S. R., Gray, G. E., Kotloff, K. L., Gay, C. L., … Huang, Y. (2024). Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae400

Saad-Roy, C. M., Morris, S. E., Boots, M., Baker, R. E., Lewis, B. L., Farrar, J., Marathe, M. V., Graham, A. L., Levin, S. A., Wagner, C. E., Metcalf, C. J. E., & Grenfell, B. T. (2024). Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy. PLOS Computational Biology, 20(8), e1012211. https://doi.org/10.1371/journal.pcbi.1012211

Kumar, V., Verma, A., Singh, R., Garg, P., Sharma, S. K., Singh, H. N., Mishra, S. K., & Kumar, S. (2024). Recombinant vaccines: Current updates and future prospects. Asian Pacific Journal of Tropical Medicine, 17(8), 338–350. https://doi.org/10.4103/apjtm.apjtm_854_23

Kota, K. P., Trakht, I., Kalantarov, G., Ordonez, D., Wei, J., Trefry, S., Bavari, E., Richardson, J., Zamani, R., Raney, C., Nasar, F., Daugherty, B., Lederman, S., & Bavari, S. (2024). High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization. Microorganisms, 12(8), 1503. https://doi.org/10.3390/microorganisms12081503

Bidari, S., & Yang, W. (2024). Global resurgence of measles in the vaccination era and influencing factors. International Journal of Infectious Diseases, 147, 107189. https://doi.org/10.1016/j.ijid.2024.107189

Fisher, L. H., Kee, J. J., Liu, A., Espinosa, C. M., Randhawa, A. K., Ludwig, J., Magaret, C. A., Robinson, S. T., Gilbert, P. B., Hyrien, O., Kublin, J. G., Rouphael, N., Falsey, A. R., Sobieszczyk, M. E., El Sahly, H. M., Grinsztejn, B., Gray, G. E., Kotloff, K. L., Gay, C. L., … Leathers, V. (2024). SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals. JAMA Network Open, 7(5), e2412835. https://doi.org/10.1001/jamanetworkopen.2024.12835

McDonnell, J., Cousins, K., Younger, M. E. M., Lane, A., Abolhassani, H., Abraham, R. S., Al-Tamemi, S., Aldave-Becerra, J. C., Al-Faris, E. H., Alfaro-Murillo, A., AlKhater, S. A., Alsaati, N., Doss, A. M. A., Anderson, M., Angarola, E., Ariue, B., Arnold, D. E., Assa’ad, A. H., Aytekin, C., … Marsh, R. (2024). COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. Journal of Clinical Immunology, 44(4). https://doi.org/10.1007/s10875-023-01613-5

Kainth, M. K., Sembajwe, G. N., Ahn, H., Qian, M., Carrington, M., Armellino, D., & Jan, S. (2024). Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children. Vaccine, 42(12), 3122–3133. https://doi.org/10.1016/j.vaccine.2024.04.028

Levy, M. E., Yang, D., Dunne, M. M., Miley, K., Irving, S. A., Grannis, S. J., Weber, Z. A., Griggs, E. P., Spark, T. L., Bassett, E., Embi, P. J., Gaglani, M., Natarajan, K., Valvi, N. R., Ong, T. C., Naleway, A. L., Stenehjem, E., Klein, N. P., Link‐Gelles, R., … Ball, S. W. (2024). Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders. Influenza and Other Respiratory Viruses, 18(3). Portico. https://doi.org/10.1111/irv.13269

Griggs, E. P., Mitchell, P. K., Lazariu, V., Gaglani, M., McEvoy, C., Klein, N. P., Valvi, N. R., Irving, S. A., Kojima, N., Stenehjem, E., Crane, B., Rao, S., Grannis, S. J., Embi, P. J., Kharbanda, A. B., Ong, T. C., Natarajan, K., Dascomb, K., Naleway, A. L., … Tenforde, M. W. (2023). Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023. Clinical Infectious Diseases, 78(2), 338–348. https://doi.org/10.1093/cid/ciad505

van Boven, M., van Dorp, C. H., Westerhof, I., Jaddoe, V., Heuvelman, V., Duijts, L., Fourie, E., Sluiter-Post, J., van Houten, M. A., Badoux, P., Euser, S., Herpers, B., Eggink, D., de Hoog, M., Boom, T., Wildenbeest, J., Bont, L., Rozhnova, G., Bonten, M. J., … Bruijning-Verhagen, P. (2024). Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study. PLOS Computational Biology, 20(1), e1011832. https://doi.org/10.1371/journal.pcbi.1011832

Souza, M. S., Farias, J. P., Andreata‐Santos, R., Silva, M. P., Brito, R. D. da S., Duarte Barbosa da Silva, M., Peter, C. M., Cirilo, M. V. de F., Luiz, W. B., Birbrair, A., Vidal, P. O., de Castro‐Amarante, M. F., Candido, E. D., Munhoz, A. S., de Mello Malta, F., Dorlass, E. G., Machado, R. R. G., Pinho, J. R. R., Oliveira, D. B. L., … Amorim, J. H. (2024). Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future. Journal of Medical Virology, 96(2). Portico. https://doi.org/10.1002/jmv.29416

Strizki, J. M., Gaspar, J. M., Howe, J. A., Hutchins, B., Mohri, H., Nair, M. S., Kinek, K. C., McKenna, P., Goh, S. L., & Murgolo, N. (2024). Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Antimicrobial Agents and Chemotherapy, 68(1). https://doi.org/10.1128/aac.00953-23

Pires Farias, J., Andreata-Santos, R., Dalety da Silva Brito, R., Silva Souza, M., Moreira Costa Fogaça, M., Ramos Pinheiro, J., Ferreira da Cruz, E., Liang, W., Simões, R. da C., Barros Luiz, W., Birbrair, A., Oliveira Vidal, P., Terzi Maricato, J., Torres Braconi, C., Ferreira, L. C. de S., Ramos Janini, L. M., & Amorim, J. H. (2023). The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.02857-23

Silva Souza, M., Pires Farias, J., Barros Luiz, W., Birbrair, A., Durães-Carvalho, R., de Souza Ferreira, L. C., & Amorim, J. H. (2023). Immune targets to stop future SARS-CoV-2 variants. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.02892-23

Holodniy, M., Pei, Y., Stack, G., Wade, C. L., Agrawal, Y., Barasch, N., Baddoura, F., Carmen Frias-Kletecka, M., Stacey Klutts, J., & Wang-rodriguez, J. (2023). 2353. SARS-CoV-2 Variants among US Veterans after COVID-19 Bivalent Vaccine Administration. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1974

Rolfes, M. A., Talbot, H. K., Grace Morrissey, K., Stockwell, M., Maldonado, Y. A., McLean, H., Lutrick, K., Bowman, N. M., Rao, S., Salvatore, P. P., Izurieta, H., Schmitz, J., Zhu, Y., Hart, K. W., Battan-Wraith, S., Merrill, L. S., McLaren, S. H., Sano, E., Sarnquist, C., … Grijalva, C. G. (2023). 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.150

Soni, M. K., Migliori, E., Fu, J., Assal, A., Chan, H. T., Pan, J., Khatiwada, P., Ciubotariu, R., May, M. S., Pereira, M. R., De Giorgi, V., Sykes, M., Mapara, M. Y., & Muranski, P. J. (2023). The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212203

Xie, J., Kuppermann, N., Florin, T. A., Tancredi, D. J., Funk, A. L., Kim, K., Salvadori, M. I., Yock-Corrales, A., Shah, N. P., Breslin, K. A., Chaudhari, P. P., Bergmann, K. R., Ahmad, F. A., Nebhrajani, J. R., Mintegi, S., Gangoiti, I., Plint, A. C., Avva, U. R., Gardiner, M. A., … Freedman, S. B. (2023). Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children. Open Forum Infectious Diseases, 10(10). https://doi.org/10.1093/ofid/ofad485

Kehrer, T., Cupic, A., Ye, C., Yildiz, S., Bouhaddou, M., Crossland, N. A., Barrall, E. A., Cohen, P., Tseng, A., Çağatay, T., Rathnasinghe, R., Flores, D., Jangra, S., Alam, F., Mena, I., Aslam, S., Saqi, A., Rutkowska, M., Ummadi, M. R., … Miorin, L. (2023). Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Cell Host & Microbe, 31(10), 1668-1684.e12. https://doi.org/10.1016/j.chom.2023.08.003

Patel, P., Schrader, K. E., Rice, C. E., Rowley, E., Cree, R. A., DeSilva, M. B., Embi, P. J., Gaglani, M., Grannis, S. J., Ong, T. C., Stenehjem, E., Naleway, A. L., Ball, S., Natarajan, K., Klein, N. P., Adams, K., Kharbanda, A., Ray, C., Link-Gelles, R., & Tenforde, M. W. (2023). Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022. Open Forum Infectious Diseases, 10(11). https://doi.org/10.1093/ofid/ofad474

Ben-Tov, A., Lebwohl, B., Banon, T., Chodick, G., Kariv, R., Assa, A., Gazit, S., & Patalon, T. (2023). BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign. Viruses, 15(9), 1968. https://doi.org/10.3390/v15091968

Rybkina, K., Bell, J. N., Bradley, M. C., Wohlbold, T., Scafuro, M., Meng, W., Korenberg, R. C., Davis-Porada, J., Anderson, B. R., Weller, R. J., Milner, J. D., Moscona, A., Porotto, M., Luning Prak, E. T., Pethe, K., Connors, T. J., & Farber, D. L. (2023). SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19. Journal of Experimental Medicine, 220(8). https://doi.org/10.1084/jem.20221518

Saad-Roy, C. M., Morris, S. E., Baker, R. E., Farrar, J., Graham, A. L., Levin, S. A., Wagner, C. E., Metcalf, C. Jessica. E., & Grenfell, B. T. (2023). Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease. Journal of The Royal Society Interface, 20(205). https://doi.org/10.1098/rsif.2023.0247

Sergeeva, A. P., Katsamba, P. S., Liao, J., Sampson, J. M., Bahna, F., Mannepalli, S., Morano, N. C., Shapiro, L., Friesner, R. A., & Honig, B. (2023). Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity. Journal of Molecular Biology, 435(15), 168187. https://doi.org/10.1016/j.jmb.2023.168187

Embi, P. J., Levy, M. E., Patel, P., DeSilva, M. B., Gaglani, M., Dascomb, K., Dunne, M. M., Klein, N. P., Ong, T. C., Grannis, S. J., Natarajan, K., Yang, D.-H., Stenehjem, E., Zerbo, O., McEvoy, C., Rao, S., Thompson, M. G., Konatham, D., Irving, S. A., … Naleway, A. L. (2023). Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. Vaccine, 41(37), 5424–5434. https://doi.org/10.1016/j.vaccine.2023.05.038

Theodore, D. A., Branche, A. R., Zhang, L., Graciaa, D. S., Choudhary, M., Hatlen, T. J., Osman, R., Babu, T. M., Robinson, S. T., Gilbert, P. B., Follmann, D., Janes, H., Kublin, J. G., Baden, L. R., Goepfert, P., Gray, G. E., Grinsztejn, B., Kotloff, K. L., Gay, C. L., … Leathers, V. (2023). Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults. JAMA Network Open, 6(7), e2323349. https://doi.org/10.1001/jamanetworkopen.2023.23349

Long, J., Soni, M., Muranski, P., Miller, M. J., Conry-Cantilena, C., & De Giorgi, V. (2023). Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1207638

Ren, J.-X., Gao, Q., Zhou, X.-C., Chen, L., Guo, W., Feng, K.-Y., Lu, L., Huang, T., & Cai, Y.-D. (2023). Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes. Biology, 12(7), 947. https://doi.org/10.3390/biology12070947

Link-Gelles, R., Weber, Z. A., Reese, S. E., Payne, A. B., Gaglani, M., Adams, K., Kharbanda, A. B., Natarajan, K., DeSilva, M. B., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Embi, P. J., Dunne, M. M., Dickerson, M., McEvoy, C., Arndorfer, J., … Tenforde, M. W. (2023). Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023. American Journal of Transplantation, 23(7), 1062–1076. https://doi.org/10.1016/j.ajt.2023.06.004

Adams, K., Riddles, J. J., Rowley, E. A. K., Grannis, S. J., Gaglani, M., Fireman, B., Hartmann, E., Naleway, A. L., Stenehjem, E., Hughes, A., Dalton, A. F., Natarajan, K., Dascomb, K., Raiyani, C., Irving, S. A., Sloan-Aagard, C., Kharbanda, A. B., DeSilva, M. B., Dixon, B. E., … Tenforde, M. W. (2023). Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study. The Lancet Regional Health - Americas, 23, 100530. https://doi.org/10.1016/j.lana.2023.100530

Bozio, C. H., Butterfield, K. A., Briggs Hagen, M., Grannis, S., Drawz, P., Hartmann, E., Ong, T. C., Fireman, B., Natarajan, K., Dascomb, K., Gaglani, M., DeSilva, M. B., Yang, D.-H., Midgley, C. M., Dixon, B. E., Naleway, A. L., Grisel, N., Liao, I. C., Reese, S. E., … Stenehjem, E. (2023). Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance. The Journal of Infectious Diseases, 227(12), 1348–1363. https://doi.org/10.1093/infdis/jiad040

Dalton, A. F., Weber, Z. A., Allen, K. S., Stenehjem, E., Irving, S. A., Spark, T. L., Adams, K., Zerbo, O., Lazariu, V., Dixon, B. E., Dascomb, K., Hartmann, E., Kharbanda, A. B., Ong, T. C., DeSilva, M. B., Beaton, M., Gaglani, M., Patel, P., Naleway, A. L., … Tenforde, M. W. (2023). Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness. Clinical Infectious Diseases, 76(9), 1615–1625. https://doi.org/10.1093/cid/ciad003

Dawood, F. S., Couture, A., Zhang, X., Stockwell, M. S., Porucznik, C. A., Stanford, J. B., Hetrich, M., Veguilla, V., Thornburg, N., Heaney, C. D., Wang, J., Duque, J., Jeddy, Z., Deloria Knoll, M., & Karron, R. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Responses After Community Infections in Children and Adults. Open Forum Infectious Diseases, 10(5). https://doi.org/10.1093/ofid/ofad168

Poggio, E., Vallese, F., Hartel, A. J. W., Morgenstern, T. J., Kanner, S. A., Rauh, O., Giamogante, F., Barazzuol, L., Shepard, K. L., Colecraft, H. M., Clarke, O. B., Brini, M., & Calì, T. (2023). Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M. Cell Death & Disease, 14(4). https://doi.org/10.1038/s41419-023-05817-w

DeSilva, M. B., Mitchell, P. K., Klein, N. P., Dixon, B. E., Tenforde, M. W., Thompson, M. G., Naleway, A. L., Grannis, S. J., Ong, T. C., Natarajan, K., Reese, S. E., Zerbo, O., Kharbanda, A. B., Patel, P., Stenehjem, E., Raiyani, C., Irving, S. A., Fadel, W. F., Rao, S., … Gaglani, M. (2022). Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022. The Journal of Infectious Diseases, 227(8), 961–969. https://doi.org/10.1093/infdis/jiac458

Muri, J., Cecchinato, V., Cavalli, A., Shanbhag, A. A., Matkovic, M., Biggiogero, M., Maida, P. A., Moritz, J., Toscano, C., Ghovehoud, E., Furlan, R., Barbic, F., Voza, A., De Nadai, G., Cervia, C., Zurbuchen, Y., Taeschler, P., Murray, L. A., Danelon-Sargenti, G., … Robbiani, D. F. (2023). Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nature Immunology, 24(4), 604–611. https://doi.org/10.1038/s41590-023-01445-w

Voss, E. A., Shoaibi, A., Yin Hui Lai, L., Blacketer, C., Alshammari, T., Makadia, R., Haynes, K., Sena, A. G., Rao, G., van Sandijk, S., Fraboulet, C., Boyer, L., Le Carrour, T., Horban, S., Morales, D. R., Martínez Roldán, J., Ramírez-Anguita, J. M., Mayer, M. A., de Wilde, M., … Ryan, P. B. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine, 58, 101932. https://doi.org/10.1016/j.eclinm.2023.101932

Bourdon, P. S., & Pantazatos, S. P. (2023). Why a major study on myocarditis risk following COVID vaccination should not influence public-health policy. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1126945

Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., Hartmann, E., Dickerson, M., Stenehjem, E., Kharbanda, A. B., Han, J., Spark, T. L., Irving, S. A., Dixon, B. E., Zerbo, O., … Tenforde, M. W. (2023). Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. JAMA Network Open, 6(3), e232598. https://doi.org/10.1001/jamanetworkopen.2023.2598

Farias, J. P., Pinheiro, J. R., Andreata‐Santos, R., Fogaça, M. M. C., da Silva Brito, R. D., da Cruz, E. F., de Castro‐Amarante, M. F., Pereira, S. S., dos Santos Almeida, S., Moreira, L. M., da Conceição Simões, R., Luiz, W. B., Birbrair, A., Belmok, A., Ribeiro, B. M., Maricato, J. T., Braconi, C. T., de Souza Ferreira, L. C., Janini, L. M. R., & Amorim, J. H. (2023). The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS‐CoV‐2 variant. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28481

Mena Lora, A. J., Long, J. E., Huang, Y., Baden, L. R., El Sahly, H. M., Follmann, D., Goepfert, P., Gray, G., Grinsztejn, B., Kotloff, K., Rouphael, N., Sobieszczyk, M., Walsh, S. R., Andriesen, J., Shah, K. A., Zhang, Y., Gilbert, P., Janes, H., Gay, C. L., … Wallace, S. E. (2023). Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA Network Open, 6(1), e2251974. https://doi.org/10.1001/jamanetworkopen.2022.51974

M, R. T. (2023). Viral Induced Coagulopathy: A Formidable Foe or a Benevolent Friend. Vaccines & Vaccination Open Access, 8(1), 1–4. https://doi.org/10.23880/vvoa-16000158

Kumar, A., Asghar, A., Singh, H. N., Faiq, M. A., Kumar, S., Narayan, R. K., Kumar, G., Dwivedi, P., Sahni, C., Jha, R. K., Kulandhasamy, M., Prasoon, P., Sesham, K., Kant, K., & Pandey, S. N. (2023). SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis. JMIR Bioinformatics and Biotechnology, 4, e42700. https://doi.org/10.2196/42700

Stockwell, M. S., Porucznik, C. A., Dixon, A., Duque, J., Stanford, J. B., Veguilla, V., & Dawood, F. S. (2022). Factors Associated with Intention to Vaccinate Children 0-11 Years of Age Against COVID-19. The Journal of the American Board of Family Medicine, 35(6), 1174–1178. https://doi.org/10.3122/jabfm.2022.220150r1